Get complete Patent Opposition Report for Elan Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Elan Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2645106Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
EP1793855Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1
EP1991267Dec 20, 2017Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab1